ArticleMediators of inflammation2026
Urinary Polycyclic Aromatic Hydrocarbons and Advanced Cardiovascular-Kidney-Metabolic Syndrome: Inflammatory-Nutritional Pathways as Mediators.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urinary Polycyclic Aromatic Hydrocarbons and Advanced Cardiovascular-Kidney-Metabolic Syndrome: Inflammatory-Nutritional Pathways as Mediators.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPolycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants linked to adverse health outcomes. Their role in the different statuses of Cardiovascular-Kidney-Metabolic (CKM) syndrome remains poorly understood.
methodsA cross-sectional analysis of 11,043 participants was conducted using data from NHANES. Urinary PAH levels were measured, and advanced CKM status was assessed using established diagnostic criteria. Mediation analysis was performed to evaluate the role of the red blood cell distribution width-to-albumin ratio (RAR).
resultsHigher urinary levels of PAHs, particularly 2-NAP and 2-FLU, were significantly associated with advanced CKM syndrome (p < 0.05). Exposure-response relationships and threshold effects were observed for these key PAHs. Mediation analysis identified RAR as a novel biomarker, explaining 6.13%-37.81% of the association depending on the specific metabolite.
conclusionsThis study reveals that PAHs are independently and jointly associated with advanced CKM status, with RAR serving as a critical mediator. These findings underscore the importance of reducing environmental PAH exposure and highlight RAR as a potential biomarker for early detection and risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.